Clinical Trial

Combined Training (Strength and Endurance) and the Serum Levels of Myostatin and Hormone-sensitive Lipase in Overweight and Obese Men

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial investigated the effects of upper body-based and lower body-based combined training on serum levels of myostatin (MSTN) and hormone-sensitive lipase (HSL) in overweight and obese men. Myostatin is a myokine involved in the regulation of skeletal muscle growth and adipose tissue metabolism, while HSL is a key enzyme involved in lipolysis and fat mobilization. Thirty-six overweight and obese men were assigned to either an upper body combined training group, a lower body combined training group, or a non-exercising control group. The intervention consisted of 10 weeks of combined resistance and aerobic training performed three times per week. Serum levels of MSTN and HSL were measured before and after the intervention to determine whether upper body-focused and lower body-focused combined training produce different effects on markers associated with muscle growth and lipid metabolism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-14.
Trial Details
NCT Number NCT07658261
Lead Sponsor Arya Habibi
Conditions Overweight (BMI > 25), Obesity (BMI>30)
Enrollment 36 participants
Start Date 2024-05-01
Primary Completion 2024-05-01 (estimated)
Study Completion 2024-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-23